Literature DB >> 25366400

Mass spectrometric analysis of rat cerebrospinal fluid proteins following exposure to the neurotoxicant carbonyl sulfide.

O Lardinois1, P J Kirby, D L Morgan, R C Sills, K B Tomer, L J Deterding.   

Abstract

RATIONALE: Using a proteomic-based approach we have investigated possible altered expression of a range of cerebral spinal fluid (CSF) proteins following exposure to the neurotoxicant carbonyl sulfide (COS). CSF is ideal for the investigation of markers of brain injury or disease since it is secreted from several central nervous system structures and changes in the CSF composition may reflect brain insult and many pathological processes.
METHODS: Animals were placed in exposure chambers and were exposed to 0 ppm or 500 ppm COS for 1, 2 or 3 days, 6 h per day. After the last inhalation exposure, 50-70 μL CSF sample was obtained by lumbar puncture. CSF samples were analyzed by electrospray ionization mass spectrometry (ESI-MS) on either a Premier quadrupole time-of-flight (QTOF) or an Agilent 6340 ion trap and by matrix-assisted laser desorption/ionization (MALDI)-MS on a 4800 MALDI-TOF/TOF analyzer.
RESULTS: The dynamic range of abundance of the identified proteins spanned over more than three orders of magnitude. The four most abundant proteins identified (albumin, cystatin C, serotransferrin, transthyretin) are major proteins that are present in both CSF and blood at high levels but the fifth most abundant protein identified (prostaglandin H2D isomerase) is the second most abundant protein in human CSF and is secreted and synthesized in the rat central nervous system. No significant differences were observed between COS-treated CSF samples and the control CSF samples because of blood contamination.
CONCLUSIONS: Quantitative MS protein analyses of rat CSF is limited by the low sample volumes that can practicably be obtained from rats and the low protein concentrations in rat CSF. Results of this work suggest a clear need for CSF collection that would minimize blood contamination. Published in 2014. This article is a U.S. Government work and is in the public domain in the USA. Published in 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25366400      PMCID: PMC4220307          DOI: 10.1002/rcm.7046

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  32 in total

1.  A procedure for direct lumbar puncture in rats.

Authors:  José L De la Calle; Carlos L Paíno
Journal:  Brain Res Bull       Date:  2002-11-30       Impact factor: 4.077

Review 2.  CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.

Authors:  Kaj Blennow
Journal:  Expert Rev Mol Diagn       Date:  2005-09       Impact factor: 5.225

Review 3.  Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.

Authors:  Mark D'Ascenzo; Norman R Relkin; Kelvin H Lee
Journal:  Curr Opin Mol Ther       Date:  2005-12

4.  Development of a percutaneous cerebrospinal fluid collection technique in F-344 rats and evaluation of cell counts and total protein concentrations.

Authors:  Alok K Sharma; Albert E Schultze; Dale M Cooper; Rachel Y Reams; William H Jordan; Paul W Snyder
Journal:  Toxicol Pathol       Date:  2006       Impact factor: 1.902

Review 5.  Recent advances in quantitative neuroproteomics.

Authors:  George E Craft; Anshu Chen; Angus C Nairn
Journal:  Methods       Date:  2013-04-25       Impact factor: 3.608

6.  Cerebrospinal fluid sampling by lumbar puncture in rats - repeated measurements of nitric oxide metabolites.

Authors:  Xianjun Wang; Shinji Kimura; Takashi Yazawa; Naoto Endo
Journal:  J Neurosci Methods       Date:  2004-12-30       Impact factor: 2.390

7.  Distribution of antihistamines into the CSF following intranasal delivery.

Authors:  K J Chou; M D Donovan
Journal:  Biopharm Drug Dispos       Date:  1997-05       Impact factor: 1.627

8.  Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid.

Authors:  Jing Zhang; David R Goodlett; Elaine R Peskind; Joseph F Quinn; Yong Zhou; Qin Wang; Catherine Pan; Eugene Yi; Jimmy Eng; Ruedi H Aebersold; Thomas J Montine
Journal:  Neurobiol Aging       Date:  2005-02       Impact factor: 4.673

9.  Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.

Authors:  Peter Brechlin; Olaf Jahn; Petra Steinacker; Lukas Cepek; Hartmut Kratzin; Stefan Lehnert; Sarah Jesse; Brit Mollenhauer; Hans A Kretzschmar; Jens Wiltfang; Markus Otto
Journal:  Proteomics       Date:  2008-10       Impact factor: 3.984

10.  Identification of a brain-specific human cerebrospinal fluid glycoprotein, beta-trace protein.

Authors:  M G Harrington; R Aebersold; B M Martin; C R Merril; L Hood
Journal:  Appl Theor Electrophor       Date:  1993
View more
  1 in total

1.  An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study.

Authors:  Jonathan Royds; Hilary Cassidy; Melissa J Conroy; Margaret R Dunne; David Matallanas; Joanne Lysaght; Connail McCrory
Journal:  J Neuroimmune Pharmacol       Date:  2020-11-20       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.